Does CARVEDILOL Cause Mobility decreased? 43 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 43 reports of Mobility decreased have been filed in association with CARVEDILOL (Carvedilol Phosphate). This represents 0.3% of all adverse event reports for CARVEDILOL.
43
Reports of Mobility decreased with CARVEDILOL
0.3%
of all CARVEDILOL reports
0
Deaths
27
Hospitalizations
How Dangerous Is Mobility decreased From CARVEDILOL?
Of the 43 reports, 27 (62.8%) required hospitalization, and 1 (2.3%) were considered life-threatening.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CARVEDILOL. However, 43 reports have been filed with the FAERS database.
What Other Side Effects Does CARVEDILOL Cause?
Hypotension (1,822)
Dyspnoea (1,143)
Dizziness (1,138)
Drug ineffective (1,102)
Fatigue (1,020)
Completed suicide (1,019)
Bradycardia (861)
Toxicity to various agents (690)
Cardiac failure (636)
Asthenia (562)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
Which CARVEDILOL Alternatives Have Lower Mobility decreased Risk?
CARVEDILOL vs CASIMERSEN
CARVEDILOL vs CASIRIVIMAB
CARVEDILOL vs CASIRIVIMAB\IMDEVIMAB
CARVEDILOL vs CASPOFUNGIN
CARVEDILOL vs CATEQUENTINIB